Further to Andy's email below, we have written a spec review document at http://www.biodas.org/wiki/Spec_Review, which is still a work in progress as the DAS spec will probably always be to a degree.
To reiterate, this document is "to make the document more consistent with common usage and add official support for the "sources" metadata command (from 1.53E and DAS/2) and to reduce complexity and confusion by removing unused features." It's editable (if you register with the site and log in). So we encourage people to either edit or make suggestions via the das email lists. We have also created another document so we can all propose new extensions and ways forward to improve the above "consolidated" spec at http://www.biodas.org/wiki/DAS_Plans Cheers Joanthan. ------------------------------------------------------------ Hi all, Over the last couple of weeks there have been a few meetings on the Hinxton campus aimed at exploring options for reconciling the two versions of the DAS spec. Involved were myself, Gregg Helt, Jonathan Warren, Felix Kokocinski, Phil Jones, Henning Hermjakob and Tim Hubbard. As a first step we have conducted a review of the current 1.53 spec with a view to updating it. The aim is to make the document more consistent with common usage, add official support for the "sources" metadata command (from 1.53E and DAS/2) and to reduce complexity and confusion by removing unused features. Another mail will be sent out soon with the conclusions so that they can be discussed before any changes are made. Cheers, Andy -- The Wellcome Trust Sanger Institute is operated by Genome Research Limited, a charity registered in England with number 1021457 and a company registered in England with number 2742969, whose registered office is 215 Euston Road, London, NW1 2BE. _______________________________________________ DAS mailing list [email protected] http://lists.open-bio.org/mailman/listinfo/das
